Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.65 |
| ▸ | AKR1C3 | P42330 | 9/20 | 0.59 |
| ▸ | AKR1C2 | P52895 | 9/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.59 |
| ▸ | POLB | P06746 | 2/20 | 0.59 |
| ▸ | NPC1 | O15118 | 1/20 | 0.57 |
| ▸ | RAB9A | P51151 | 1/20 | 0.57 |
| ▸ | GAA | P10253 | 2/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | HPGD | P15428 | 1/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | CA1 | P00915 | 1/20 | 0.54 |
| ▸ | CA2 | P00918 | 1/20 | 0.54 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzene SCHEMBL29227606 | 0.98 | ALDH1A1 (0.63) | ALDH1A1SMN1; SMN2AKR1C3AKR1C2KDM4E | |
| SCHEMBL5307872 | 0.92 | NPC1 (0.63) | ALDH1A1SMN1; SMN2AKR1C3AKR1C2KDM4E | |
| SCHEMBL4128750 | 0.90 | ALDH1A1 (0.65) | ALDH1A1SMN1; SMN2AKR1C3AKR1C2KDM4E | |
| SCHEMBL3037245 | 0.90 | ALDH1A1 (0.65) | ALDH1A1SMN1; SMN2AKR1C3AKR1C2KDM4E | |
| SCHEMBL27939607 | 0.89 | CDC25B (0.66) | ALDH1A1SMN1; SMN2AKR1C3AKR1C2KDM4E | |
| SCHEMBL523820 | 0.88 | POLB (0.63) | ALDH1A1SMN1; SMN2AKR1C3AKR1C2KDM4E | |
| SCHEMBL5736385 | 0.88 | KDM4E (0.60) | ALDH1A1SMN1; SMN2AKR1C3AKR1C2KDM4E | |
| SCHEMBL1956889 | 0.88 | KDM4E (0.60) | ALDH1A1SMN1; SMN2AKR1C3AKR1C2KDM4E | |
| SCHEMBL7016460 | 0.88 | SMN1; SMN2 (0.57) | ALDH1A1SMN1; SMN2AKR1C3AKR1C2KDM4E | |
| SCHEMBL14608284 | 0.88 | SMN1; SMN2 (0.57) | ALDH1A1SMN1; SMN2AKR1C3AKR1C2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 280 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119119834-A | Concrete composite floor for outdoor wet area and preparation method thereof | 黄山精强建材股份有限公司 | 2024-12-13 | — | — | CN | claimed |
| CN-118341173-A | Filter bag with welding agent material and preparation method thereof | 江苏奥凯环境技术有限公司 | 2024-07-16 | — | — | CN | claimed |
| EP-3517553-B1 | CATALYST COMPONENT FOR USE IN OLEFIN POLYMERIZATION, CATALYST, AND APPLICATIONS THEREOF | CHINA PETROLEUM & CHEM CORP (CN) | 2023-11-08 | — | — | EP | claimed |
| CN-109749067-B | Polyester resin with excellent flexibility for powder coating and preparation method thereof | 安徽永利新材料科技有限公司 | 2021-01-26 | — | — | CN | claimed |
| EP-3135697-B1 | CATALYST COMPONENT FOR OLEFIN POLYMERIZATION AND CATALYST THEREOF | CHINA PETROLEUM & CHEM CORP (CN) | 2019-08-14 | — | — | EP | claimed |
| CN-1308604-A | 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia | AMERICAN HOME PROD (US) | 2001-08-15 | — | — | CN | claimed |
| EP-4683934-A1 | SYSTEM | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2026-01-28 | — | — | EP | disclosed |
| EP-4655355-A1 | PHOTOACTIVE FLUORESCENT COMPOUNDS AND USE THEREOF FOR LABELING OF PROTEINS | Eikon Therapeutics, Inc. (US) | 2025-12-03 | — | — | EP | disclosed |
| EP-4596606-A1 | CURABLE COMPOSITION | Daicel Corporation (JP) | 2025-08-06 | — | — | EP | disclosed |
| US-20250214921-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | KAO CORPORATION (JP) | 2025-07-03 | — | — | US | disclosed |
| US-20250214920-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | KAO CORPORATION (JP) | 2025-07-03 | — | — | US | disclosed |
| CN-119948083-A | Curable composition | 株式会社大赛璐 | 2025-05-06 | — | — | CN | disclosed |
| US-20250092020-A1 | IDO/TDO Inhibitor | GENERAL INCORPORATED ASSOCIATION PHARMA VALLEY PROJECT SUPPORTING ORGANIZATION (JP) | 2025-03-20 | — | — | US | disclosed |
| US-3991042-A | Basic azo dyestuffs containing a benzthiazole and a tetrahydroquinoline nucleus | BAYER AKTIENGESELLSCHAFT (DT) | 1976-11-09 | — | — | US | disclosed |
| US-3971807-A | BENZINDOLE | BAYER AKTIENGESELLSCHAFT (DT) | 1976-07-27 | — | — | US | disclosed |
| US-3959310-A | BENZINDOLE | BAYER AKTIENGESELLSCHAFT (DT) | 1976-05-25 | — | — | US | disclosed |
| US-3956264-A | Basic azo dyestuffs having indolyl-methyleneamino substituent in the diazo component | BAYER AKTIENGESELLSCHAFT (DT) | 1976-05-11 | — | — | US | disclosed |
| US-3950347-A | NAPHTHOLACTAM DYESTUFFS | BAYER AKTIENGESELLSCHAFT (DT) | 1976-04-13 | — | — | US | disclosed |
| US-3948877-A | POLYACRYLONITRILE, ACID MODIFIED POLYESTERS OR POLYAMIDES | BAYER AKTIENGESELLSCHAFT (DT) | 1976-04-06 | — | — | US | disclosed |
| US-3947477-A | Process for the preparation of aminohydroxyanthraquinones | BAYER AKTIENGESELLSCHAFT (DT) | 1976-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250214920-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | CYP4F2, DUOX1, BCKDK | ALDH1A1 973/4885SMN1; SMN2 4175/4885AKR1C3 145/4885 |
| US-20250214921-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | HSD17B7, HSD17B12, BCKDK | ALDH1A1 699/4885SMN1; SMN2 4516/4885AKR1C3 68/4885 |
| US-20250092020-A1 | IDO/TDO Inhibitor | IDO1, IDO2, TDO2 | ALDH1A1 3331/4885SMN1; SMN2 1967/4885AKR1C3 534/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.